What an exciting year for ACCP and Pharmacotherapy Publications, Inc. (PPI)! ACCP celebrated its 40th anniversary, Pharmacotherapy completed publication of its 39th volume, and ACCP’s new journal, Journal of the American College of Clinical Pharmacy (JACCP), marked a successful first year. The PPI board of directors, editors, and editorial teams worked diligently this year to achieve its mission – to disseminate cutting-edge pharmacotherapeutic and clinical pharmacy scholarship to improve human health.
We are grateful to so many in ACCP whose contributions helped achieve this and look forward to an even more productive 2020. As PPI kicks off the New Year, I would like to share with you a few highlights and opportunities to engage.
As drug therapy, clinical pharmacy practice, and the publishing industry continue to evolve, PPI strives to identify the best ways to deliver value to its stakeholders – its readers, authors, and reviewers. PPI focuses on developing live programming to promote scholarly development, publishing regular podcasts, disseminating research and resources through social media outlets, and exploring new publications and services. For example, Pharmacotherapy is increasing its impact and relevance as a journal dedicated to clinical pharmacology and pharmacotherapeutics by issuing a request for proposals on drug- or drug class–specific consensus recommendations to guide the use and management of a specific drug or class of drugs to improve health or prevent disease. Potential authors with established records in practice, research, and publication should consider submitting a proposal in 2020. Additional information is available on the Pharmacotherapy website (https://accpjournals.onlinelibrary.wiley.com/pb-assets/assets/18759114/RFP%20Consensus%20Recs_v3.pdf).
JACCP provides a home for high-quality clinical pharmacy practice research, reviews, and editorials; publication will increase from six issues in 2019 to eight issues in 2020. JACCP published its first themed issue in August 2019, with invited manuscripts focused on clinical pharmacy practice in community settings. A second themed issue on clinical pharmacy practice around the world is planned for publication in 2020. Manuscripts should be submitted by January 15, 2020, to be considered for this special issue.
It has been exciting to see the overwhelming response to JACCP and the many submissions this first year. We appreciate your continued support as the journal expands in the coming year.
PPI’s partnership with its publisher, Wiley-Blackwell, allows its journals to reach a broad audience of libraries and also keeps it on the forefront of advances in the publishing industry. Both Pharmacotherapy and JACCP are hybrid journals, meaning authors may choose to publish under the terms of the journal’s standard copyright agreement or as Online Open under the terms of a Creative Commons License. As an ACCP member, you have access to both journals, and PPI’s hybrid model allows its authors the option to expand readership beyond traditional subscribers. The PPI board of directors, journal editors, and editorial staff will continue to assess the evolving publication environment and seek input to guide decisions such as this to provide readers optimal opportunities.
Our journals continue to increase their social media presence, and we hope you will engage with our editors and authors on Twitter (@PharmacoJournal and @JACCPJournal) and Facebook (@pharmacotherapy). PPI is committed to the clear vision of improving human health through disseminating high-quality pharmacotherapeutic and clinical pharmacy scholarship in 2020, and we look forward to working with you to ensure the success of ACCP and our journals.